Although antiretroviral regimens were freely provided to HIV/AIDS patients in China based on NFATP, the time when to initiate ART was updated from CD4 <200cells/ul to any CD4 cells levels, which reduced the incidence of OIs in China. This evidence concerns the gene NFATC2 and AIDS.